Cargando…

PREPARATION FROM HUMAN RED CELLS OF A SUBSTANCE INHIBITING VIRUS HEMAGGLUTINATION

Methods have been described for the extraction and purification of an agent inhibiting the hemagglutination of red cells by influenza (PR8) and mumps viruses. Human red cells have served as the chief source of the inhibitor but the latter has also been found in human lung. The active extracts have b...

Descripción completa

Detalles Bibliográficos
Autores principales: deBurgh, Patrick M., Yu, Pen-Chung, Howe, Calderon, Bovarnick, Max
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1948
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2135763/
https://www.ncbi.nlm.nih.gov/pubmed/19871694
_version_ 1782142971316011008
author deBurgh, Patrick M.
Yu, Pen-Chung
Howe, Calderon
Bovarnick, Max
author_facet deBurgh, Patrick M.
Yu, Pen-Chung
Howe, Calderon
Bovarnick, Max
author_sort deBurgh, Patrick M.
collection PubMed
description Methods have been described for the extraction and purification of an agent inhibiting the hemagglutination of red cells by influenza (PR8) and mumps viruses. Human red cells have served as the chief source of the inhibitor but the latter has also been found in human lung. The active extracts have been purified to the extent that 0.1 gamma of material suffices to inhibit one hemagglutinating dose of virus. Incomplete chemical characterization of the most highly purified fractions available indicates the presence of 2.6 per cent nitrogen, at least 50 per cent of polysaccharide, and no phosphorus. In the ultracentrifuge the purified preparation behaves as a polydisperse macromolecular substance. The active material can be obtained from red cell stroma in an ether- and chloroform-soluble form which, on further treatment, can be converted into chloroform-insoluble material. It is possible that the former represents more closely the virus receptor as it exists in the red cell. The purified inhibitor is inactivated on incubation with the virus at 37°C. The nature of this effect is being investigated.
format Text
id pubmed-2135763
institution National Center for Biotechnology Information
language English
publishDate 1948
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21357632008-04-18 PREPARATION FROM HUMAN RED CELLS OF A SUBSTANCE INHIBITING VIRUS HEMAGGLUTINATION deBurgh, Patrick M. Yu, Pen-Chung Howe, Calderon Bovarnick, Max J Exp Med Article Methods have been described for the extraction and purification of an agent inhibiting the hemagglutination of red cells by influenza (PR8) and mumps viruses. Human red cells have served as the chief source of the inhibitor but the latter has also been found in human lung. The active extracts have been purified to the extent that 0.1 gamma of material suffices to inhibit one hemagglutinating dose of virus. Incomplete chemical characterization of the most highly purified fractions available indicates the presence of 2.6 per cent nitrogen, at least 50 per cent of polysaccharide, and no phosphorus. In the ultracentrifuge the purified preparation behaves as a polydisperse macromolecular substance. The active material can be obtained from red cell stroma in an ether- and chloroform-soluble form which, on further treatment, can be converted into chloroform-insoluble material. It is possible that the former represents more closely the virus receptor as it exists in the red cell. The purified inhibitor is inactivated on incubation with the virus at 37°C. The nature of this effect is being investigated. The Rockefeller University Press 1948-01-01 /pmc/articles/PMC2135763/ /pubmed/19871694 Text en Copyright © Copyright, 1948, by The Rockefeller Institute for Medical Research New York This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
deBurgh, Patrick M.
Yu, Pen-Chung
Howe, Calderon
Bovarnick, Max
PREPARATION FROM HUMAN RED CELLS OF A SUBSTANCE INHIBITING VIRUS HEMAGGLUTINATION
title PREPARATION FROM HUMAN RED CELLS OF A SUBSTANCE INHIBITING VIRUS HEMAGGLUTINATION
title_full PREPARATION FROM HUMAN RED CELLS OF A SUBSTANCE INHIBITING VIRUS HEMAGGLUTINATION
title_fullStr PREPARATION FROM HUMAN RED CELLS OF A SUBSTANCE INHIBITING VIRUS HEMAGGLUTINATION
title_full_unstemmed PREPARATION FROM HUMAN RED CELLS OF A SUBSTANCE INHIBITING VIRUS HEMAGGLUTINATION
title_short PREPARATION FROM HUMAN RED CELLS OF A SUBSTANCE INHIBITING VIRUS HEMAGGLUTINATION
title_sort preparation from human red cells of a substance inhibiting virus hemagglutination
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2135763/
https://www.ncbi.nlm.nih.gov/pubmed/19871694
work_keys_str_mv AT deburghpatrickm preparationfromhumanredcellsofasubstanceinhibitingvirushemagglutination
AT yupenchung preparationfromhumanredcellsofasubstanceinhibitingvirushemagglutination
AT howecalderon preparationfromhumanredcellsofasubstanceinhibitingvirushemagglutination
AT bovarnickmax preparationfromhumanredcellsofasubstanceinhibitingvirushemagglutination